These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 34461442)

  • 1. Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke.
    Kenda J; Lovrič D; Škerget M; Milivojević N
    J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106072. PubMed ID: 34461442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy.
    Costentin G; Ozkul-Wermester O; Triquenot A; Cam-Duchez VL; Massy N; Benhamou Y; Massardier E
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105942. PubMed ID: 34175640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ischemic Stroke and Vaccine-Induced Immune Thrombotic Thrombocytopenia following COVID-19 Vaccine: A Case Report with Systematic Review of the Literature.
    Cascio Rizzo A; Giussani G; Agostoni EC
    Cerebrovasc Dis; 2022; 51(6):722-734. PubMed ID: 35512656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A review of the potential mechanisms and proposed management.
    Alam W
    Sci Prog; 2021; 104(2):368504211025927. PubMed ID: 34120531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aortic thrombosis and acute limb ischemia after ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccination: a case of vaccine-induced thrombocytopenia and thrombosis (VITT).
    Vierstraete M; Sabbe T
    Acta Chir Belg; 2023 Jun; 123(3):329-332. PubMed ID: 34890294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Gabarin N; Arnold DM; Nazy I; Warkentin TE
    Semin Hematol; 2022 Apr; 59(2):89-96. PubMed ID: 35512906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical care pathway for the evaluation of patients with suspected VITT after ChAdOx1 nCoV-19 vaccination.
    Lee AYY; Al Moosawi M; Peterson EA; McCracken RK; Wong SKW; Nicolson H; Chan V; Smith T; Wong MP; Lee LJ; Griffiths C; Rahal B; Parkin S; Afra K; Ambler K; Chen LYC; Field TS; Lindsay HC; Lavoie M; Li C; Migneault D; Naus M; Piszczek J; Rahmani P; Sreenivasan G; Wan T; Yee A; Zypchen L; Sweet D
    Blood Adv; 2022 Jun; 6(11):3315-3320. PubMed ID: 35201292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential mechanisms of vaccine-induced thrombosis.
    Marietta M; Coluccio V; Luppi M
    Eur J Intern Med; 2022 Nov; 105():1-7. PubMed ID: 35953336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond.
    Greinacher A; Warkentin TE
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):1-10. PubMed ID: 38066843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT).
    Greinacher A; Schönborn L; Siegerist F; Steil L; Palankar R; Handtke S; Reder A; Thiele T; Aurich K; Methling K; Lalk M; Völker U; Endlich N
    Semin Hematol; 2022 Apr; 59(2):97-107. PubMed ID: 35512907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis: A Review.
    Rizk JG; Gupta A; Sardar P; Henry BM; Lewin JC; Lippi G; Lavie CJ
    JAMA Cardiol; 2021 Dec; 6(12):1451-1460. PubMed ID: 34374713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine associated benign headache and cutaneous hemorrhage after ChAdOx1 nCoV-19 vaccine: A cohort study.
    Schultz NH; Søraas AVL; Sørvoll IH; Akkök ÇA; Vetlesen A; Bhamra JS; Ahlen MT; Holme PA; Aamodt AH; Skagen K; Skattør TH; Skjelland M; Wiedmann MK
    J Stroke Cerebrovasc Dis; 2023 Jan; 32(1):106860. PubMed ID: 36403363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.
    Greinacher A; Selleng K; Palankar R; Wesche J; Handtke S; Wolff M; Aurich K; Lalk M; Methling K; Völker U; Hentschker C; Michalik S; Steil L; Reder A; Schönborn L; Beer M; Franzke K; Büttner A; Fehse B; Stavrou EX; Rangaswamy C; Mailer RK; Englert H; Frye M; Thiele T; Kochanek S; Krutzke L; Siegerist F; Endlich N; Warkentin TE; Renné T
    Blood; 2021 Dec; 138(22):2256-2268. PubMed ID: 34587242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal Aspects of VITT.
    Schönborn L; Greinacher A
    Semin Hematol; 2022 Apr; 59(2):108-114. PubMed ID: 35512899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis.
    Pavord S; Scully M; Hunt BJ; Lester W; Bagot C; Craven B; Rampotas A; Ambler G; Makris M
    N Engl J Med; 2021 Oct; 385(18):1680-1689. PubMed ID: 34379914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome in vaccine-induced immune thrombocytopenia and thrombosis.
    Schönborn L; Seck SE; Thiele T; Kaderali L; Hoffmann T; Hlinka A; Lindhoff-Last E; Völker U; Selleng K; Buoninfante A; Cavaleri M; Greinacher A
    J Thromb Haemost; 2023 Sep; 21(9):2519-2527. PubMed ID: 37394120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-platelet factor 4 antibodies causing VITT do not cross-react with SARS-CoV-2 spike protein.
    Greinacher A; Selleng K; Mayerle J; Palankar R; Wesche J; Reiche S; Aebischer A; Warkentin TE; Muenchhoff M; Hellmuth JC; Keppler OT; Duerschmied D; Lother A; Rieg S; Gawaz MP; Mueller KAL; Scheer CS; Napp M; Hahnenkamp K; Lucchese G; Vogelgesang A; Flöel A; Lovreglio P; Stufano A; Marschalek R; Thiele T;
    Blood; 2021 Oct; 138(14):1269-1277. PubMed ID: 34280256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective review COVID-19 vaccine induced thrombotic thrombocytopenia and cerebral venous thrombosis-what can we learn from the immune response.
    Franceschi AM; Petrover DR; McMahon TM; Libman RB; Giliberto L; Clouston SAP; Castillo M; Kirsch C
    Clin Imaging; 2022 Oct; 90():63-70. PubMed ID: 35926315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    McGonagle D; De Marco G; Bridgewood C
    J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.